HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)

234 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q2 2021.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 103,864,409 shares of 183,255,226 outstanding shares and own 56.68% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (13,268,720 shares), VANGUARD GROUP INC (9,319,728 shares), BAKER BROS. ADVISORS LP (8,131,678 shares), TANG CAPITAL MANAGEMENT LLC (7,907,087 shares), BlackRock Inc. (7,521,849 shares), ArrowMark Colorado Holdings LLC (5,903,968 shares), STATE STREET CORP (4,712,719 shares), JPMORGAN CHASE & CO (4,510,102 shares), UBS OCONNOR LLC (4,425,000 shares), and WELLINGTON MANAGEMENT GROUP LLP (4,221,689 shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.